home / stock / axgn / axgn news

AXGN News and Press, Axogen Inc. From 02/13/24

Stock Information
Company Name: Axogen Inc.
Stock Symbol: AXGN
Market: NASDAQ
Website: axogeninc.com
Menu
AXGN AXGN Quote AXGN Short AXGN News AXGN Articles AXGN Message Board
Get AXGN Alerts

News, Short Squeeze, Breakout and More Instantly...
AXGN - Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024

ALACHUA, Fla. and TAMPA, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2023 fourth quarter and full-year financial results on Tuesday...
AXGN - Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced making Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) in connection with t...

AXGN - Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS

2024-01-21 16:50:33 ET More on Pacific Biosciences of California, AVITA Medical, etc. AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum Pacific Biosciences' Revio And Onso Lead Looks Priced In For Now Reassessing Pacific Biosciences: Deep...

AXGN - Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap

REPOSE ® met its primary endpoint of non-inferiority between the pain visual analog scale outcomes for neurectomy with Axoguard Nerve Cap ® vs. standard-of-care neurectomy at Month 12. Axoguard Nerve Cap demonstrated statistical superiority vs. standard-of-care neurect...
AXGN - (AXGN) Technical Data

2024-01-06 07:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

AXGN - RCAC, AIMD and MESO among mid-day movers

2024-01-05 12:31:54 ET Gainers: Revelstone Capital Acquisition Corp ( RCAC ) +90% . Ainos ( AIMD ) +72% . Banzai International ( BNZI ) +62% . Safe and Green Development ( SGD ) +41% . Swvl Holdings ( SWVL ) +41% . Zoomcar Ho...

AXGN - Cyclacel Pharmaceuticals, Angiodynamic among healthcare movers

2024-01-05 10:00:03 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...
AXGN - Axogen climbs 4% on guiding FY revenue above consensus

2024-01-05 03:22:06 ET More on AxoGen AxoGen: Continued Sales Growth, 3x Added Capacity, Strong Outlook (Rating Upgrade) Axogen CEO Karen Zaderej to retire Axogen has named Nir Naor CFO For further details see: Axogen climbs 4% on guiding FY revenue above...

AXGN - Axogen CEO Karen Zaderej to retire

2024-01-04 16:46:24 ET More on AxoGen AxoGen: Continued Sales Growth, 3x Added Capacity, Strong Outlook (Rating Upgrade) Axogen has named Nir Naor CFO AxoGen Non-GAAP EPS of $0.01 beats by $0.07, revenue of $41.3M beats by $1.03M Seeking Alpha’s Quant ...

AXGN - Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023

ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2023 revenue. Prelimina...
Previous 10 Next 10